San Francisco, California, United States
A seasoned executive in the Medical Device industry and currently the Co-CEO of MicroPort Scientific Corporation, a globally recognized leader in the development, manufacturing, and commercialization of high-end medical devices. With a strong background in the biomedical field and business management, I played a pivotal role in driving MicroPort’s expansion into international markets, particularly in cardiovascular, orthopedics, endovascular, and surgical robotics. I joined MicroPort in 2012, bringing extensive experience in the medical device industry. Before assuming the role of Co-CEO, I held various leadership positions within the company, including Chief International Business Officer (CIBO), where I successfully spearheaded global strategies, partnerships, and regulatory approvals for MicroPort’s innovative products. Under my leadership, the company has strengthened its presence in the developed and emerging markets, while advancing cutting-edge technologies such as robotic-assisted telesurgery. Prior to MicroPort, I held key roles in multinational medical device and investment banking firms, where I gained deep expertise in R&D/product development, commercialization, and market development, and capital raising/M&A and financial strategy. My technical acumen and business insight have been instrumental in MicroPort’s growth as a China-domiciled company with a global footprint. My leadership philosophy emphasizes collaboration, innovation, and sustainable growth, positioning MicroPort as a key player in the next generation of medical advancements as we continue to push the boundaries of medical technology, improving patient outcomes worldwide.
C-Suite medical device executive with over 20 years industry experience. Head of International Business for one of the leading global medical device companies based in China.
Member of company's senior executive management team. Improved operational execution for the company's flagship product for its wound closure business division, including establishing a new distribution channel for key growth product. Led process to restructure company's balance sheet through a $200M capital raising effort with private equity investors. Transaction highlights include: $800M acquisition of American Medical Instruments Holdings, a manufacturer of single-use disposable medical instruments; $200M acquisition of Quill Medical, developer of a novel barbed suture technology; a Joint Venture for a drug-loaded biomaterial with Genzyme Corp; a collaboration for a novel-stem cell technology with Athersys, Inc.
Expanded product platforms for our Wound Closure products business focused on surgeons and our Interventional products business focused on interventional radiologists.
Focused on acquisitions/transactions to transform what was primarily an R&D based company into a more fully-vertically integrated company with its own manufacturing and distribution capabilities.
Lead transaction execution finance professional focused on clients in the biotech, medtech, and specialty pharma industries. Successfully advised on over 25 corporate financing and M&A transactions totaling over $5 billion in value in over 8 year banking career.